**Core Concept:**
Phocomelia is a rare congenital disorder characterized by the absence of one or both upper limbs. It occurs due to developmental defects in the limbs during pregnancy, often caused by exposure to teratogenic substances. Teratogens are substances that can interfere with normal fetal development, leading to birth defects.

**Why the Correct Answer is Right:**
The correct answer, thalidomide (Option C), is a well-known example of a teratogenic drug. It was introduced as a sedative and antiemetic (anti-nausea) drug in the 1950s and 60s. However, it was later found to cause severe birth defects, including phocomelia, when taken by pregnant women. Thalidomide is a glutathione-S-tranferase (GST) inhibitor, which disrupts the normal growth and development of the embryo.

**Why Each Wrong Option is Incorrect:**
Option A (methotrexate) is a chemotherapy drug used to treat cancer and autoimmune disorders. While it can cause birth defects, it is not directly associated with phocomelia.

Option B (isoniazid) is an anti-tuberculosis drug. Although it can cause birth defects, it is not directly linked to phocomelia either.

Option D (isoniazid) is a drug used for treating tuberculosis, similar to Option B. While it can cause birth defects, it is not directly associated with phocomelia.

**Clinical Pearl:**
Thalidomide is a cautionary tale of the dangers of taking medications during pregnancy without proper consultation with a healthcare professional. This case highlights the importance of informed decision-making regarding medication use during pregnancy to avoid severe birth defects in babies.

**Correct Answer:** Phocomelia is primarily associated with exposure to thalidomide (Option C) during pregnancy. It is crucial for pregnant women to discuss any medication use with their healthcare provider to minimize the risk of birth defects in their offspring.